SCHEMBL981628

SCHEMBL981628

BrCc1cc[nH]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28209678 0.83 TSHR (0.38)
SCHEMBL27747352 0.79
SCHEMBL5662539 0.75
SCHEMBL28293382 0.74
SCHEMBL156217 0.72
SCHEMBL1162272 0.72
SCHEMBL2270853 0.72
SCHEMBL2005072 0.72
Hydrochloric Acid SCHEMBL7241248 0.70
SCHEMBL357316 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119351388-A Application of porous carrier material in microorganism immobilization 南京大学 2025-01-24 CN disclosed
CN-114539241-B Pleuromutilin derivative containing thiazole-pyridine methyl aromatic heterocyclic quaternary ammonium salt side chain and preparation method and application thereof 西咸新区沣厚原创医药科技有限公司 2024-06-04 CN disclosed
CN-114456160-B Oxadiazole-pyridine quaternary ammonium salt side chain-containing pleuromutilin derivative with drug-resistant bacteria resisting activity, and preparation method and application thereof 西安康远晟生物医药科技有限公司 2024-02-23 CN disclosed
CN-114539241-A Pleuromutilin derivative containing thiazole-picolyl aromatic heterocyclic quaternary ammonium salt side chain and preparation method and application thereof 陕西科技大学 2022-05-27 CN disclosed
CN-114456160-A Oxadiazole-pyridine quaternary ammonium salt side chain containing pleuromutilin derivative with drug-resistant bacterium resisting activity and preparation method and application thereof 西安康远晟生物医药科技有限公司 2022-05-10 CN disclosed
CN-104428293-B Adjust the benzimidazole of TNF α UCB生物制药私人有限公司 2018-06-08 CN disclosed
CN-107252429-A New antiinflammatory 雷斯韦洛吉克斯公司 2017-10-17 CN disclosed
CN-102458405-B Novel anti-inflammatory agents 雷斯韦洛吉克斯公司 2017-06-23 CN disclosed
CN-106536515-A Compounds useful as immunomodulators 百时美施贵宝公司 2017-03-22 CN disclosed
US-9249154-B2 Compounds and therapeutic use thereof for protein kinase inhibition WU ZHANGGUI (US) 2016-02-02 US disclosed
US-20110009415-A1 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses WU, ZHANGGUI (CN) 2011-01-13 US disclosed
US-20110009415-A1 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses WU, ZHANGGUI (CN) 2011-01-13 US disclosed
US-20110009415-A1 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses WU, ZHANGGUI (CN) 2011-01-13 US disclosed
EP-2241569-A1 THIENOPYRIDAZINE COMPOUNDS, THEIR PREPARATIONS, PHARMACEUTICAL COMPOSITIONS AND USES Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory (CN) 2010-10-20 EP disclosed
EP-2241569-A1 THIENOPYRIDAZINE COMPOUNDS, THEIR PREPARATIONS, PHARMACEUTICAL COMPOSITIONS AND USES Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory (CN) 2010-10-20 EP disclosed
US-20090275585-A1 Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition WU ZHANGGUI 2009-11-05 US disclosed
US-20090275585-A1 Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition WU ZHANGGUI 2009-11-05 US disclosed
US-20090275585-A1 Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition WU ZHANGGUI 2009-11-05 US disclosed
US-4440779-A Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO., INC. (US) 1984-04-03 US disclosed
EP-0068460-A1 Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO. INC. (US) 1983-01-05 EP disclosed